Macrovascular Outcomes with Antidiabetic Drugs: Ongoing Studies Hertzel C. Gerstein MD MSc FRCPC Professor & Population Health Institute Chair in Diabetes Research McMaster…
LECTURE 10-97 Outline General endpoint considerations Surrogate endpoints Composite endpoints and recurrent events Safety outcomes (adverse events) Composite Event (def.)…